News / National
Medicinal mbanje products launched in Zimbabwe
09 Nov 2024 at 17:10hrs | Views
In a historic move for Zimbabwe's healthcare sector, Ivory Medicinal has officially launched its pioneering medicinal cannabis product line, CannaQure. This breakthrough in medical treatment aims to harness the therapeutic benefits of cannabis to provide natural relief for various health conditions.
Ivory Medicinal, a leading healthcare company licensed as a Good Manufacturing Practice (GMP) complementary medicine manufacturer by the Medicines Control Authority of Zimbabwe (MCAZ), has set its sights on revolutionizing wellness in Zimbabwe. The company's flagship product line, CannaQure, offers a range of cannabis-based therapeutic products designed to support individuals suffering from chronic pain, stress, sleep disturbances, and other ailments.
In a press release, the company emphasized that CannaQure is formulated to complement traditional medicine, providing alternative treatment options that offer enhanced wellness and symptom relief. The products are rich in cannabinoids, particularly Cannabidiol (CBD), and are crafted to be non-psychoactive, meaning they will not cause a "high" or any narcotic effects.
"These products have been meticulously developed to adhere to the highest safety and quality standards as required by MCAZ," the company stated. "CannaQure aims to provide accessible, reliable, and scientifically-backed solutions for patients seeking alternative therapies."
According to Ivory Medicinal's General Manager, Mr. Nash Kadzinga, the launch of CannaQure is a landmark moment in the country's healthcare development. "This launch is more than just a product introduction; it is a milestone in Zimbabwe's healthcare evolution," he said. "CannaQure reflects our commitment to offering safe, effective, and accessible medicinal cannabis products that cater to the needs of patients looking for alternative treatments. We are proud to offer a natural, reliable option that is grounded in science."
Kadzinga stressed that the core values of Ivory Medicinal's mission include education, transparency, and quality. "With CannaQure, we aim to lead a new era in healthcare in Zimbabwe—one where patients are empowered with choices, and nature's remedies play a key role in their wellness journey."
As part of its vision, Ivory Medicinal is committed to expanding the awareness and understanding of medicinal cannabis in Zimbabwe. The company plans to work closely with healthcare providers and the local community to address misconceptions and raise awareness about the plant's therapeutic value, which has been utilized across cultures for centuries.
Ivory Medicinal's efforts are expected to provide a significant opportunity for Zimbabweans to experience the potential benefits of medicinal cannabis, a plant that is becoming increasingly recognized globally for its healing properties. With its launch of CannaQure, the company aims to position itself as a leader in the emerging medicinal cannabis market in Zimbabwe.
Ivory Medicinal, a leading healthcare company licensed as a Good Manufacturing Practice (GMP) complementary medicine manufacturer by the Medicines Control Authority of Zimbabwe (MCAZ), has set its sights on revolutionizing wellness in Zimbabwe. The company's flagship product line, CannaQure, offers a range of cannabis-based therapeutic products designed to support individuals suffering from chronic pain, stress, sleep disturbances, and other ailments.
In a press release, the company emphasized that CannaQure is formulated to complement traditional medicine, providing alternative treatment options that offer enhanced wellness and symptom relief. The products are rich in cannabinoids, particularly Cannabidiol (CBD), and are crafted to be non-psychoactive, meaning they will not cause a "high" or any narcotic effects.
"These products have been meticulously developed to adhere to the highest safety and quality standards as required by MCAZ," the company stated. "CannaQure aims to provide accessible, reliable, and scientifically-backed solutions for patients seeking alternative therapies."
According to Ivory Medicinal's General Manager, Mr. Nash Kadzinga, the launch of CannaQure is a landmark moment in the country's healthcare development. "This launch is more than just a product introduction; it is a milestone in Zimbabwe's healthcare evolution," he said. "CannaQure reflects our commitment to offering safe, effective, and accessible medicinal cannabis products that cater to the needs of patients looking for alternative treatments. We are proud to offer a natural, reliable option that is grounded in science."
Kadzinga stressed that the core values of Ivory Medicinal's mission include education, transparency, and quality. "With CannaQure, we aim to lead a new era in healthcare in Zimbabwe—one where patients are empowered with choices, and nature's remedies play a key role in their wellness journey."
As part of its vision, Ivory Medicinal is committed to expanding the awareness and understanding of medicinal cannabis in Zimbabwe. The company plans to work closely with healthcare providers and the local community to address misconceptions and raise awareness about the plant's therapeutic value, which has been utilized across cultures for centuries.
Ivory Medicinal's efforts are expected to provide a significant opportunity for Zimbabweans to experience the potential benefits of medicinal cannabis, a plant that is becoming increasingly recognized globally for its healing properties. With its launch of CannaQure, the company aims to position itself as a leader in the emerging medicinal cannabis market in Zimbabwe.
Source - The Chronicle
